Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

[1]  D. Fitzmaurice,et al.  Self-monitoring and self-management of oral anticoagulation. , 2016, The Cochrane database of systematic reviews.

[2]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[3]  Joanna M. Wardlaw,et al.  Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden , 2014, Neurology.

[4]  Yunlong Xia,et al.  The Early Stage of the Atrial Electroanatomic Remodeling as Substrates for Atrial Fibrillation in Hypertensive Patients , 2014, Journal of the American Heart Association.

[5]  Y. Adler,et al.  Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. , 2014, JAMA.

[6]  J. Piccini,et al.  Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation. , 2014, Journal of the American College of Cardiology.

[7]  S. Suissa,et al.  Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes. , 2014, European heart journal.

[8]  E. Pokushalov,et al.  Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience. , 2014, Heart rhythm.

[9]  Frank Beckers,et al.  Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.

[10]  Richard Platt,et al.  Launching PCORnet, a national patient-centered clinical research network , 2014, Journal of the American Medical Informatics Association : JAMIA.

[11]  B. Nordestgaard,et al.  Antihypertensive treatment and risk of atrial fibrillation: a nationwide study. , 2014, European heart journal.

[12]  Stanley Nattel,et al.  Role of the Autonomic Nervous System in Atrial Fibrillation: Pathophysiology and Therapy , 2014, Circulation research.

[13]  P. Ellinor,et al.  Emerging Directions in the Genetics of Atrial Fibrillation , 2014, Circulation research.

[14]  Alan Bernjak,et al.  Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk , 2014, Diabetes.

[15]  Deepak L. Bhatt,et al.  Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety , 2014, The New England journal of medicine.

[16]  M. Cleman,et al.  Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. , 2014, Heart rhythm.

[17]  S. Testa,et al.  A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin , 2014, Internal and Emergency Medicine.

[18]  Niels Voigt,et al.  Calcium dysregulation in atrial fibrillation: the role of CaMKII , 2014, Front. Pharmacol..

[19]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[20]  R. Brandes,et al.  Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. , 2014, Antioxidants & redox signaling.

[21]  Nazem Akoum,et al.  Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. , 2014, JAMA.

[22]  D. Vilchez,et al.  The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases , 2014, Current genomics.

[23]  S. Nattel,et al.  Role of Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology and Fibrillation in the Dog , 2014, Circulation.

[24]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[25]  F. Hoogstra-Berends,et al.  Activation of Histone Deacetylase-6 Induces Contractile Dysfunction Through Derailment of &agr;-Tubulin Proteostasis in Experimental and Human Atrial Fibrillation , 2014, Circulation.

[26]  Na Li,et al.  Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation , 2014, Circulation.

[27]  J. Moss.  Left Atrial Appendage Exclusion for Prevention of Stroke in Atrial Fibrillation: Review of Minimally Invasive Approaches , 2014, Current Cardiology Reports.

[28]  Christopher A. Aakre,et al.  Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation , 2012, Stroke.

[29]  Laura G. Qualls,et al.  Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation. , 2014, Journal of cardiac failure.

[30]  Hugh Calkins,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2014, Journal of the American College of Cardiology.

[31]  S. Nattel,et al.  Fibrillation Initiation , Maintenance , and Progression , 2014 .

[32]  S. Daskalopoulou,et al.  Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery. , 2014, Current vascular pharmacology.

[33]  J. Ioannidis,et al.  Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. , 2013, Journal of the American College of Cardiology.

[34]  M. Adams,et al.  An Adaptive Physical Activity Intervention for Overweight Adults: A Randomized Controlled Trial , 2013, PloS one.

[35]  E. Vittinghoff,et al.  Atrial Ectopy as a Predictor of Incident Atrial Fibrillation , 2013, Annals of Internal Medicine.

[36]  A. Malhotra,et al.  Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation , 2013, Journal of the American Heart Association.

[37]  J. Menzin,et al.  Impact of Atrial Fibrillation on Stroke‐Related Healthcare Costs , 2013, Journal of the American Heart Association.

[38]  R. Califf,et al.  Embedding cardiovascular research into practice. , 2013, JAMA.

[39]  W. Abhayaratna,et al.  Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. , 2013, JAMA.

[40]  M. Ackerman,et al.  Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. , 2013, Journal of the American College of Cardiology.

[41]  F. Gaita,et al.  Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. , 2013, Journal of the American College of Cardiology.

[42]  G. Lip,et al.  Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. , 2013, Chest.

[43]  G. Boriani.  Predicting the quality of anticoagulation during warfarin therapy: the basis for an individualized approach. , 2013, Chest.

[44]  D. V. Van Wagoner,et al.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. , 2013, International journal of cardiology.

[45]  R. Weiss,et al.  Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation , 2013, Circulation.

[46]  Stanley Nattel,et al.  Management of atrial fibrillation in the year 2033: new concepts, tools, and applications leading to personalized medicine. , 2013, The Canadian journal of cardiology.

[47]  Ashok J. Shah,et al.  Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study. , 2013, Journal of the American College of Cardiology.

[48]  U. Ravens,et al.  Atrial selectivity of antiarrhythmic drugs , 2013, The Journal of physiology.

[49]  Mitchell W Krucoff,et al.  Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). , 2013, American heart journal.

[50]  K. Uhlig,et al.  Self-Measured Blood Pressure Monitoring in the Management of Hypertension , 2013, Annals of Internal Medicine.

[51]  C. O'connor,et al.  Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism. , 2013, JACC. Heart failure.

[52]  J. Ferreira,et al.  Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies , 2013, Heart.

[53]  D. Rueckert,et al.  Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: A 2-center study , 2013, Heart rhythm.

[54]  Harvey V Fineberg,et al.  The paradox of disease prevention: celebrated in principle, resisted in practice. , 2013, JAMA.

[55]  A. McLellan,et al.  The Role of Adenosine Following Pulmonary Vein Isolation in Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Systematic Review , 2013, Journal of cardiovascular electrophysiology.

[56]  R. Hoeltgen,et al.  Does the number of simultaneously activated electrodes during phased RF multielectrode ablation of atrial fibrillation influence the incidence of silent cerebral microembolism? , 2013, Heart rhythm.

[57]  A. Kroon,et al.  Clinical end points in baroreflex activation therapy: what do we need to know? , 2013, Expert review of cardiovascular therapy.

[58]  A. Sheikh,et al.  Experiences of patients and professionals participating in the HITS home blood pressure telemonitoring trial: a qualitative study , 2013, BMJ Open.

[59]  S. Yusuf,et al.  Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. , 2013, International journal of cardiology.

[60]  E. Warburton,et al.  Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke , 2013, Neurology.

[61]  N. Lowres,et al.  Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke. , 2013, International journal of cardiology.

[62]  David D. McManus,et al.  Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium , 2013, Journal of the American Heart Association.

[63]  B. Dawn,et al.  Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA My Heart Study. , 2013, Journal of the American College of Cardiology.

[64]  E. Powers,et al.  Diversity in the origins of proteostasis networks — a driver for protein function in evolution , 2013, Nature Reviews Molecular Cell Biology.

[65]  B. Scherlag,et al.  Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation. , 2013, Heart rhythm.

[66]  Mårten Rosenqvist,et al.  Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population: Implications for Stroke Prevention , 2013, Circulation.

[67]  Nancy R. Cook,et al.  Novel genetic markers improve measures of atrial fibrillation risk prediction , 2013, European heart journal.

[68]  S. Scalvini,et al.  Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study) , 2013, Trials.

[69]  Dhaval Shah,et al.  Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. , 2012, Journal of the American College of Cardiology.

[70]  Yuan Zhang,et al.  Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. , 2013, Heart rhythm.

[71]  M. Reeves,et al.  Does diffusion-weighted imaging predict short-term risk of stroke in emergency department patients with transient ischemic attack? , 2013, Annals of emergency medicine.

[72]  Mark Tomlinson,et al.  Standardized Functions for Smartphone Applications: Examples from Maternal and Child Health , 2012, International journal of telemedicine and applications.

[73]  Martin Adam,et al.  Premature Atrial Contractions in the General Population: Frequency and Risk Factors , 2012, Circulation.

[74]  Wouter-Jan Rappel,et al.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.

[75]  D. Lane,et al.  Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis. , 2012, Patient education and counseling.

[76]  Tom Wong,et al.  Spatiotemporal Behavior of High Dominant Frequency During Paroxysmal and Persistent Atrial Fibrillation in the Human Left Atrium , 2012, Circulation. Arrhythmia and electrophysiology.

[77]  G. Lip,et al.  New anticoagulant treatments to protect against stroke in atrial fibrillation , 2012, Heart.

[78]  David D McManus,et al.  Novel Risk Factors for Atrial Fibrillation: Useful for Risk Prediction and Clinical Decision Making? , 2012, Circulation.

[79]  Robert M Califf,et al.  Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. , 2012, JAMA.

[80]  P. Vardas,et al.  Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[81]  J. McMurray,et al.  Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. , 2012, Journal of the American College of Cardiology.

[82]  J. Halperin,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[83]  F. Hoogstra-Berends,et al.  Heat shock protein-inducing compounds as therapeutics to restore proteostasis in atrial fibrillation. , 2012, Trends in cardiovascular medicine.

[84]  S. Ratcliffe,et al.  Randomized Ablation Strategies for the Treatment of Persistent Atrial Fibrillation: RASTA Study , 2012, Circulation. Arrhythmia and electrophysiology.

[85]  S. Nattel,et al.  Novel molecular targets for atrial fibrillation therapy , 2012, Nature Reviews Drug Discovery.

[86]  Mark A. Wood,et al.  Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation. , 2012, Journal of the American College of Cardiology.

[87]  R. Califf,et al.  Impediments to Clinical Research in the United States , 2012, Clinical pharmacology and therapeutics.

[88]  F. Hoogstra-Berends,et al.  Loss of Proteostatic Control as a Substrate for Atrial Fibrillation: A Novel Target for Upstream Therapy by Heat Shock Proteins , 2012, Front. Physio..

[89]  Sanjiv M. Narayan,et al.  Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[90]  D. Rosenbaum,et al.  Connexin Gene Transfer Preserves Conduction Velocity and Prevents Atrial Fibrillation , 2012, Circulation.

[91]  Harlan M Krumholz,et al.  Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis , 2012, BMJ : British Medical Journal.

[92]  B. Gersh.  Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study , 2012 .

[93]  M. Gold.  Colchicine Reduces Postoperative Atrial Fibrillation: Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) Atrial Fibrillation Substudy , 2012 .

[94]  José Jalife,et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2012, Heart rhythm.

[95]  Mark E. Anderson,et al.  Oxidation of CaMKII determines the cardiotoxic effects of aldosterone , 2011, Nature Medicine.

[96]  A. Camara,et al.  Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts. , 2011, Pharmacological research.

[97]  Christopher W Ward,et al.  X-ROS Signaling: Rapid Mechano-Chemo Transduction in Heart , 2011, Science.

[98]  Godfrey L. Smith,et al.  Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention-An in vivo perspective. , 2011, Pharmacology & therapeutics.

[99]  H. Duff,et al.  Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ release , 2011, Nature Medicine.

[100]  Niels Voigt,et al.  Recent advances in the molecular pathophysiology of atrial fibrillation. , 2011, The Journal of clinical investigation.

[101]  Sanjiv M. Narayan,et al.  Repolarization Alternans Reveals Vulnerability to Human Atrial Fibrillation , 2011, Circulation.

[102]  H. Halperin,et al.  Gaps in the Ablation Line as a Potential Cause of Recovery From Electrical Isolation and Their Visualization Using MRI , 2011, Circulation. Arrhythmia and electrophysiology.

[103]  D. Bers,et al.  Reactive Oxygen Species–Activated Ca/Calmodulin Kinase II&dgr; Is Required for Late INa Augmentation Leading to Cellular Na and Ca Overload , 2011, Circulation research.

[104]  F. Lombardi,et al.  Efficacy of Acupuncture in Preventing Atrial Fibrillation Recurrences After Electrical Cardioversion , 2011, Journal of cardiovascular electrophysiology.

[105]  S. Nattel,et al.  Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. , 2011, Cardiovascular research.

[106]  John Spertus,et al.  Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[107]  R. Leman.  Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation , 2011 .

[108]  Elsayed Z Soliman,et al.  A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). , 2011, The American journal of cardiology.

[109]  A. Verma,et al.  Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. , 2011, The Canadian journal of cardiology.

[110]  Michael J Pencina,et al.  Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. , 2010, JAMA.

[111]  Michael J Pencina,et al.  Validation of an atrial fibrillation risk algorithm in whites and African Americans. , 2010, Archives of internal medicine.

[112]  Y. Liu,et al.  Taxol, a microtubule stabilizer, prevents atrial fibrillation in in vitro atrial fibrillation models using rabbit hearts. , 2010, Medical science monitor : international medical journal of experimental and clinical research.

[113]  Ulrich Schotten,et al.  Electropathological Substrate of Longstanding Persistent Atrial Fibrillation in Patients With Structural Heart Disease: Epicardial Breakthrough , 2010, Circulation.

[114]  Paul J. Wang,et al.  Safety and Efficacy of Pulmonary Vein Antral Isolation in Patients With Obstructive Sleep Apnea: The Impact of Continuous Positive Airway Pressure , 2010, Circulation. Arrhythmia and electrophysiology.

[115]  Sanghamitra Mohanty,et al.  Left Atrial Appendage: An Underrecognized Trigger Site of Atrial Fibrillation , 2010, Circulation.

[116]  G. Lip,et al.  Underuse of oral anticoagulants in atrial fibrillation: a systematic review. , 2010, The American journal of medicine.

[117]  Shien-Fong Lin,et al.  Intrinsic Cardiac Nerve Activity and Paroxysmal Atrial Tachyarrhythmia in Ambulatory Dogs , 2010, Circulation.

[118]  L. Køber,et al.  Excessive Supraventricular Ectopic Activity and Increased Risk of Atrial Fibrillation and Stroke , 2010, Circulation.

[119]  S. Hazen,et al.  Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation , 2010, Nature Medicine.

[120]  Thomas Meitinger,et al.  Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation , 2010, Nature Genetics.

[121]  Benjamin C. Sun,et al.  Development of a Novel Large Animal Model of Ischemic Heart Failure Using Autologous Platelet Aggregates , 2010, The International journal of artificial organs.

[122]  D. Levy,et al.  Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community , 2010, Circulation.

[123]  D. Fitzmaurice,et al.  Self-monitoring and self-management of oral anticoagulation. , 2010, The Cochrane database of systematic reviews.

[124]  A. Gillis.  Angiotensin-receptor blockers for prevention of atrial fibrillation--a matter of timing or target? , 2009, The New England journal of medicine.

[125]  D. Levy,et al.  Relation of multiple inflammatory biomarkers to incident atrial fibrillation. , 2009, The American journal of cardiology.

[126]  G. Marcus,et al.  Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. , 2009, Archives of internal medicine.

[127]  Bonnie Spring,et al.  Toward a transdisciplinary model of evidence-based practice. , 2009, The Milbank quarterly.

[128]  F. Harrell,et al.  Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.

[129]  A. Maggioni,et al.  Valsartan for prevention of recurrent atrial fibrillation. , 2009, The New England journal of medicine.

[130]  Christopher X. Wong,et al.  Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor". , 2009, Journal of the American College of Cardiology.

[131]  Joshua J. E. Blauer,et al.  Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients With Atrial Fibrillation , 2009, Circulation.

[132]  R. Weiss,et al.  Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. , 2009, The Journal of clinical investigation.

[133]  D. Roden,et al.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans , 2009, Nature Medicine.

[134]  G. Lip,et al.  Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. , 2009, Journal of psychosomatic research.

[135]  R. Califf,et al.  Scientific evidence underlying the ACC/AHA clinical practice guidelines. , 2009, JAMA.

[136]  D. Levy,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[137]  Wouter-Jan Rappel,et al.  Repolarization and Activation Restitution near Human Pulmonary Veins and Atrial Fibrillation Initiation a Mechanism for the Initiation of Atrial Fibrillation by Premature Beats , 2022 .

[138]  S. Nattel,et al.  Atrial structural remodeling as an antiarrhythmic target. , 2008, Journal of cardiovascular pharmacology.

[139]  D. Goff,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[140]  G. Lamas,et al.  Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. , 2007, The New England journal of medicine.

[141]  Masanori Hirose,et al.  Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites. , 2007, Cardiovascular research.

[142]  Sverker Jern,et al.  Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. , 2006, JAMA.

[143]  Gregory Y H Lip,et al.  Quality of life in patients with atrial fibrillation: a systematic review. , 2006, The American journal of medicine.

[144]  F. Sacher,et al.  Characterization of focal atrial tachycardia using high-density mapping. , 2005, Journal of the American College of Cardiology.

[145]  Ling Lu,et al.  Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. , 2005, American journal of physiology. Heart and circulatory physiology.

[146]  R. Habib,et al.  Obesity and Risk of New-Onset Atrial Fibrillation After Cardiac Surgery , 2005, Circulation.

[147]  Dietrich Andresen,et al.  Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. , 2005, European heart journal.

[148]  P. Vestergaard,et al.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. , 2005, The American journal of medicine.

[149]  H. Nakagawa,et al.  Electrical Stimulation to Identify Neural Elements on the Heart: Their Role in Atrial Fibrillation , 2005, Journal of Interventional Cardiac Electrophysiology.

[150]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[151]  José Jalife,et al.  Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. , 2005, Biophysical journal.

[152]  M. Nieminen,et al.  Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.

[153]  Paul A Friedman,et al.  Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the , 2005, Circulation.

[154]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[155]  C. Grady,et al.  Oversight of Human Participants Research: Identifying Problems To Evaluate Reform Proposals , 2004, Annals of Internal Medicine.

[156]  Y. Rudy,et al.  Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia , 2004, Nature Medicine.

[157]  B. Gersh,et al.  Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation , 2003, Circulation.

[158]  G. Lamas,et al.  Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) , 2003, Circulation.

[159]  E. Bernal,et al.  Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study , 2002, Circulation.

[160]  A. Gillis,et al.  Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation. , 2000, The American journal of cardiology.

[161]  N S Peters,et al.  Feasibility of a noncontact catheter for endocardial mapping of human ventricular tachycardia. , 1999, Circulation.

[162]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[163]  H. Mølgaard,et al.  Premature atrial beat eliciting atrial fibrillation after coronary artery bypass grafting. , 1995, Journal of electrocardiology.

[164]  Moĭbenko Aa,et al.  The heart as an endocrine organ , 1990 .

[165]  M. Weir,et al.  The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .

[166]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[167]  G. Lip,et al.  Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT 2 R 2 Score , 2022 .

[168]  Wolters Kluwer,et al.  Hrs/ehra/ecas Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: a Report of the Heart Rhythm Society (hrs) Task Force , 2022 .